All content for Antibody News is the property of The Antibody Society and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during November 1-15, 2024. Tune in to catch all the latest developments in global antibody therapeutics development.
